Development and effect evaluation of a vaccine culture medium with high antigenic activity for the prevention of porcine edema disease caused by Escherichia coli based on response surface methodology
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [16]
  • | | | |
  • Comments
    Abstract:

    [Background] Porcine edema disease caused by Escherichia coli is a major disease attacking pigs. The existing culture medium used for vaccine preparation has a low cell density.[Objective] To develop a vaccine culture medium with high antigenic activity for the prevention of porcine edema disease. [Methods] A commercially available vaccine culture medium against porcine edema disease was used as the control. The response surface methodology was employed to optimize the composition of the culture medium through single-factor experiments, Plackett-Burman (PB) design, and Box-Behnken (BB) design. The optimized culture medium was used to culture the E. coli eliciting porcine edema disease, and the antigenic activity of the culture at different time points was evaluated. In addition, the inactivated vaccine was prepared and used for animal immunization. [Results] The expanded culture of the pathogen in the developed culture medium showed that the viable cell count of the strain reached more than 5×109 CFU/mL, approximately twice that of the control group. Meanwhile, the titer of the inactivated vaccine reached 1:140 000, and the antigen protein titer peaked at the time point of 9 h. [Conclusion] The developed vaccine culture medium significantly improved the cell density and antigenic activity of E. coli causing porcine edema disease, providing technical guidance for preparing inactivated vaccines against porcine edema disease.

    Reference
    [1] BERNREITER-HOFER T, SCHWARZ L, MÜLLER E, CABAL-ROSEL A, KORUS M, MISIC D, FRANKENFELD K, ABRAHAM K, GRÜNZWEIL O, WEISS A, FEßLER AT, ALLERBERGER F, SCHWARZ S, SZOSTAK MP, RUPPITSCH W, LADINIG A, SPERGSER J, BRAUN SD, MONECKE S, EHRICHT R, et al. The pheno- and genotypic characterization of porcine Escherichia coli isolates[J]. Microorganisms, 2021, 9(8): 1676.
    [2] ROBINS-BROWNE RM, HOLT KE, INGLE DJ, HOCKING DM, YANG J, TAUSCHEK M. Are Escherichia coli pathotypes still relevant in the era of whole-genome sequencing?[J]. Frontiers in Cellular and Infection Microbiology, 2016, 6: 141.
    [3] MAINIL J. Escherichia coli virulence factors[J]. Veterinary Immunology and Immunopathology, 2013, 152(1/2): 2-12.
    [4] KOCH R. An address on cholera and its Bacillus[J]. British Medical Journal, 1884, 2(1235): 403-407.
    [5] HERMANN-BANK ML, SKOVGAARD K, STOCKMARR A, STRUBE ML, LARSEN N, KONGSTED H, INGERSLEV HC, MØLBAK L, BOYE M. Characterization of the bacterial gut microbiota of piglets suffering from new neonatal porcine diarrhoea[J]. BMC Veterinary Research, 2015, 11(1): 139.
    [6] YAKIMOVA EA, MATYASH EA, BELYAEVA AS, KAPUSTIN AV, LAISHEVTSEV AI. Etiological structure of pig colibacillosis on the territory of the Russian Federation[J]. IOP Conference Series: Earth and Environmental Science, 2021, 848(1): 012225.
    [7] 刘琳, 郭晓银, 何彦侠, 张阳, 吴保庆, 于文会, 田浪. 腹泻仔猪肠道大肠杆菌分离鉴定与毒力基因及耐药性分析[J]. 东北农业大学学报, 2022, 53(6): 65-75. LIU L, GUO XY, HE YX, ZHANG Y, WU BQ, YU WH, TIAN L. Identification, virulence gene and antibiotic resistance analysis of Escheri-chia coli isolated from diarrheic piglets[J]. Journal of Northeast Agricultural University, 2022, 53(6): 65-75 (in Chinese).
    [8] 王保宁, 贡嘎, 王刚, 黄筱均, 张璇, 强巴央宗, 索朗斯珠. 藏仔猪致病性大肠杆菌疫苗的制备及效果评价[J]. 中国人兽共患病学报, 2018, 34(1): 73-78. WANG BN, GONG G, WANG G, HUANG XJ, ZHANG X, QIANGBA YZ, SUOLANG SZ. Preparation and effect evaluation of the adjuvant vaccine of enteropathogenic Escherichia coli in Tibetan piglets[J]. Chinese Journal of Zoonoses, 2018, 34(1): 73-78 (in Chinese).
    [9] 陈章水, 崔益洙, 郭宝清, 孔令达. 新生猪腹泻大肠杆菌K_(88)K_(99)双价基因工程疫苗穴位接种免疫试验[J]. 中国农业科学, 1995, 28(1): 75-79. CHEN ZS, CUI YZ, GUO BQ, KONG LD. Newborn pig diarrhea Escherichia coli K_ (88) K_(99) double valent genetic engineering vaccine acupoint immunization test[J]. Scientia Agricultura Sinica, 1995, 28(1): 75-79 (in Chinese).
    [10] 袁万哲, 何孔旺, 陆承平. 仔猪大肠杆菌病K88-K99-987P-F41四价亚单位疫苗的研制 Ⅳ.疫苗生产与免疫效力试验[J].中国兽医学报, 2007, 27(6): 818-820, 861. YUAN WZ, HE KW, LU CP. Development of K88-K99-987P-F41 tetravalent subunit vaccine against piglet colibacillosis Ⅳ. vaccine production and immunization efficacy experiment[J]. Chinese Journal of Veterinary Science, 2007, 27(6): 818-820, 861 (in Chinese).
    [11] 冯启峥, 侯美佳, 孙思萌, 石博, 刘嘉利, 董秀梅, 张萍, 师东方. 产不耐热肠毒素大肠杆菌减毒突变菌株的毒性和免疫应答评价[J]. 中国预防兽医学报, 2021, 43(3): 310-318. FENG QZ, HOU MJ, SUN SM, SHI B, LIU JL, DONG XM, ZHANG P, SHI DF. Evaluation of the toxicity and immune response of the attenuated mutant strains of heat-labile enterotoxin-producing Escherichia coli[J]. Chinese Journal of Preventive Veterinary Medicine, 2021, 43(3): 310-318 (in Chinese).
    [12] 王劼. 产肠毒素大肠杆菌菌毛的DNA疫苗研究进展[J]. 中国畜牧兽医, 2011, 38(2): 178-181. WANG J. The review of DNA vaccine encoding the enterotoxigenic Escherichia coli (ETEC) fimbriae[J]. China Animal Husbandry & Veterinary Medicine, 2011, 38(2): 178-181 (in Chinese).
    [13] HUTER V, SZOSTAK MP, GAMPFER J, PRETHALER S, WANNER G, GABOR F, LUBITZ W. Bacterial ghosts as drug carrier and targeting vehicles[J]. Journal of Controlled Release, 1999, 61(1/2): 51-63.
    [14] YUSIBOV V, RABINDRAN S, COMMANDEUR U, TWYMAN RM, FISCHER R. The potential of plant virus vectors for vaccine production[J]. Drugs in R & D, 2006, 7(4): 203-217.
    [15] HU RJ, LI J, ZHAO YZ, LIN H, LIANG L, WANG MM, LIU HJ, MIN YN, GAO YP, YANG MM. Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC)[J]. Microbial Cell Factories, 2020, 19(1): 1-17.
    [16] JHA P, DAS AJ, DEKA SC. Optimisation of fermentation process for production of black rice wine and evaluation of its phenolic and volatile compounds[J]. Journal of the Institute of Brewing, 2018, 124(4): 485-491.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

ZHANG Yangyang, WAN Qiang, NIU Dequan, MIAO Sen, JIANG Fufeng, LIU Xiang, QU Xiaoying, ZHANG Jumei, CAI Zhihe, CHEN Bo, WU Qingping. Development and effect evaluation of a vaccine culture medium with high antigenic activity for the prevention of porcine edema disease caused by Escherichia coli based on response surface methodology[J]. Microbiology China, 2023, 50(9): 4141-4153

Copy
Share
Article Metrics
  • Abstract:214
  • PDF: 804
  • HTML: 615
  • Cited by: 0
History
  • Received:March 23,2023
  • Adopted:May 26,2023
  • Online: September 04,2023
  • Published: September 20,2023
Article QR Code